ArticleInfectious diseases and therapy2026

A Phase 1/2 Trial Evaluating the Safety and Immunogenicity of an mRNA-based Seasonal Influenza Vaccine Candidate Encoding Hemagglutinin and Neuraminidase.

Ilse De Coster et al.PubMed ↗Publisher ↗

No numbers read from the abstract.